Literature DB >> 10330085

Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, and TGFbeta3) during embryonic rat testis development.

A S Cupp1, G Kim, M K Skinner.   

Abstract

The objective of the current study was to determine the role of transforming growth factor beta (TGFbeta) during seminiferous cord formation and embryonic testis development. The expression pattern of mRNA for TGFbeta isoforms was evaluated during testis development through a quantitative reverse transcription-polymerase chain reaction (QRT-PCR) procedure. Expression of mRNA for TGFbeta1 was highest at postnatal day 0 (P0) and P10. In contrast, TGFbeta2 was high at embryonic day 15 (E15), declined at E16, and showed a transient increase at P0 through P3 of testis development. Interestingly, expression of mRNA for TGFbeta3 was high during embryonic development and then declined after P3. Immunohistochemical localization of TGFbeta1 and TGFbeta2 demonstrated expression in Sertoli cells at E14 and in the seminiferous cords at P0. Selective interstitial cells expressed high concentrations of TGFbeta1 and TGFbeta2 in P0 testis. TGFbeta3 was expressed in selective cells at the junction of the E14 testis and mesonephros. The cells expressing TGFbeta3 in the testis appeared to be preperitubular cells that resided around the seminiferous cords. TGFbeta3 was localized to gonocytes in P0 testis. TGFbeta1 was found to have no influence on seminiferous cord formation in embryonic organ cultures of E13 testis. In contrast, growth of both E13 and E14 embryonic organ cultures was inhibited by TGFbeta1 and resulted in reduced testis size (40% of controls) with fewer cords present. A P0 testis cell culture and thymidine incorporation assay were used to directly examine the effects of recombinant TGFbeta1. TGFbeta1 alone had no influence on thymidine incorporation in P0 testis cell cultures when compared to controls. Interestingly, TGFbeta1 inhibited epidermal growth factor (EGF), and 10% calf serum stimulated P0 testis cell growth but not FSH-stimulated growth. Therefore, TGFbeta1 appears to inhibit testis growth in both the embryonic and early postnatal periods. The hormonal regulation of TGFbeta expression was measured using P0 testis cell cultures and a QRT-PCR procedure for each TGFbeta isoform. High concentrations of EGF stimulated expression of mRNA for TGFbeta1 after 24 h but suppressed expression of TGFbeta3. In contrast, there was no effect of FSH on TGFbeta isoform expression. In summary, TGFbeta regulates embryonic and P0 testis growth through inhibiting the actions of positive growth factors such as EGF. In addition, EGF but not FSH appears to regulate TGFbeta isoform expression. Combined observations from the present study demonstrate that TGFbeta isoforms are differentially expressed and appear to be regulators of testis growth during the embryonic and early postnatal periods.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330085     DOI: 10.1095/biolreprod60.6.1304

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  13 in total

Review 1.  Sertoli cells--immunological sentinels of spermatogenesis.

Authors:  Gurvinder Kaur; Lea Ann Thompson; Jannette M Dufour
Journal:  Semin Cell Dev Biol       Date:  2014-03-03       Impact factor: 7.727

2.  Vascular endothelial growth factor and kinase domain region receptor are involved in both seminiferous cord formation and vascular development during testis morphogenesis in the rat.

Authors:  Rebecca C Bott; Ryann M McFee; Debra T Clopton; Candice Toombs; Andrea S Cupp
Journal:  Biol Reprod       Date:  2006-05-03       Impact factor: 4.285

3.  Inhibition of vascular endothelial growth factor receptor signal transduction blocks follicle progression but does not necessarily disrupt vascular development in perinatal rat ovaries.

Authors:  Renee M McFee; Robin A Artac; Ryann M McFee; Debra T Clopton; Robyn A Longfellow Smith; Timothy G Rozell; Andrea S Cupp
Journal:  Biol Reprod       Date:  2009-07-15       Impact factor: 4.285

Review 4.  Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis.

Authors:  Gehua Zhen; Xu Cao
Journal:  Trends Pharmacol Sci       Date:  2014-04-15       Impact factor: 14.819

5.  Transforming growth factor beta (TGFbeta1, TGFbeta2 and TGFbeta3) null-mutant phenotypes in embryonic gonadal development.

Authors:  Mushtaq A Memon; Matthew D Anway; Trevor R Covert; Mehmet Uzumcu; Michael K Skinner
Journal:  Mol Cell Endocrinol       Date:  2008-08-26       Impact factor: 4.102

6.  Transforming growth factor beta-1 decreases the yield of the second meiotic division of rat pachytene spermatocytes in vitro.

Authors:  Anne Damestoy; Marie-Hélène Perrard; Michèle Vigier; Odile Sabido; Philippe Durand
Journal:  Reprod Biol Endocrinol       Date:  2005-06-07       Impact factor: 5.211

7.  Musashi-1 maintains blood-testis barrier structure during spermatogenesis and regulates stress granule formation upon heat stress.

Authors:  Sun ErLin; Wei WenJie; Wang LiNing; Lu BingXin; Lei MingDe; Sun Yan; Han RuiFa
Journal:  Mol Biol Cell       Date:  2015-02-25       Impact factor: 4.138

8.  Long-term culture and significant expansion of human Sertoli cells whilst maintaining stable global phenotype and AKT and SMAD1/5 activation.

Authors:  Ying Guo; Yanan Hai; Chencheng Yao; Zheng Chen; Jingmei Hou; Zheng Li; Zuping He
Journal:  Cell Commun Signal       Date:  2015-03-25       Impact factor: 5.712

9.  Role of complement regulatory proteins in the survival of murine allo-transplanted Sertoli cells.

Authors:  Hak-Mo Lee; Byoung Chol Oh; Dong-Pyo Lim; Dong-Sup Lee; Jaejin Cho; Gene Lee; Jeong Ryul Lee
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

10.  Roles of CD34+ cells and ALK5 signaling in the reconstruction of seminiferous tubule-like structures in 3-D re-aggregate culture of dissociated cells from neonatal mouse testes.

Authors:  Shin-Ichi Abe; Kazuko Abe; Jidong Zhang; Tomoaki Harada; Go Mizumoto; Hiroki Oshikawa; Haruhiko Akiyama; Kenji Shimamura
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.